Community Dermatology Limited

Community Dermatology Limited manufactures Dyplens, a mobile dermatology imaging system. This device is specifically designed to capture high-quality photographs of skin lesions and transmit them securely for remote consultation by dermatologists. It is intended to support clinical decision-making in dermatology by enabling quick image-based assessments.

Community Dermatology Limited is based in the United Kingdom. While the company’s location does not inherently influence the regulatory classification or approval process of its devices, it does mean that the company operates within the EU’s regulatory framework. This includes compliance with EU Medical Device Regulations (MDR) and registration in the EUDAMED database, which is the official EU database for medical devices.

The devices manufactured by Community Dermatology Limited, such as Dyplens, are classified as Class I under EU regulations. This classification is determined by the intended purpose and risk profile of the device. Class I devices are generally considered to pose the lowest risk to patients and typically require minimal regulatory oversight, though they still must comply with EU requirements for safety, performance, and traceability, including registration in EUDAMED.

Yes, the devices from Community Dermatology Limited are listed in the EUDAMED database. This registry is the official EU system for tracking medical devices throughout their lifecycle, including manufacturing details, regulatory status, and compliance information. Listing in EUDAMED ensures transparency and allows healthcare professionals, regulators, and other stakeholders to verify the device’s legitimacy, compliance with EU regulations, and traceability—particularly important for devices like Dyplens, which are used in clinical settings.